Skip NavigationSkip to Content
Return Return to Search Results

The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps

  1. Author:
    Crozier,Ian [ORCID]
    Britson, Kyla A
    Wolfe, Daniel N [ORCID]
    Klena, John D [ORCID]
    Hensley, Lisa E
    Lee, John S [ORCID]
    Wolfraim, Larry A
    Taylor, Kimberly L
    Higgs, Elizabeth S
    Montgomery, Joel M
    Martins, Karen A

  2. Author Address

    Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., U.S. Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), Washington, DC 20201, USA., U.S. Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), Oak Ridge Institute for Science and Education (ORISE) Postdoctoral Fellow, Oak Ridge, TN 37831, USA., Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA., Integrated Research Facility, National Institute of Allergy and Infectious Diseases, Fort Detrick, MD 12116, USA., U.S. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Rockville, MD 20852, USA.,
    1. Year: 2022
    2. Date: Jul 29
    3. Epub Date: 2022 07 29
  2. Journal: Vaccines
    1. 10
    2. 8
  4. Type of Article: Article
  5. Article Number: 1213
  1. Abstract:

    The Ebola virus disease outbreak that occurred in Western Africa from 2013-2016, and subsequent smaller but increasingly frequent outbreaks of Ebola virus disease in recent years, spurred an unprecedented effort to develop and deploy effective vaccines, therapeutics, and diagnostics. This effort led to the U.S. regulatory approval of a diagnostic test, two vaccines, and two therapeutics for Ebola virus disease indications. Moreover, the establishment of fieldable diagnostic tests improved the speed with which patients can be diagnosed and public health resources mobilized. The United States government has played and continues to play a key role in funding and coordinating these medical countermeasure efforts. Here, we describe the coordinated U.S. government response to develop medical countermeasures for Ebola virus disease and we identify lessons learned that may improve future efforts to develop and deploy effective countermeasures against other filoviruses, such as Sudan virus and Marburg virus.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.3390/vaccines10081213
  3. PMID: 36016101
  4. PMCID: PMC9415766
  5. PII : vaccines10081213

Library Notes

  1. Fiscal Year: FY2021-2022
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel